XML 55 R44.htm IDEA: XBRL DOCUMENT v3.25.3
Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Numerator:        
Net loss attributable to Surgery Partners, Inc. $ (22.7) $ (31.7) $ (62.9) $ (59.6)
Weighted average common shares outstanding:        
Basic (shares) 127,206 126,172 126,932 126,093
Diluted (shares) [1] 127,206 126,172 126,932 126,093
Net loss per share attributable to common stockholders:        
Basic (in USD per share) $ (0.18) $ (0.25) $ (0.50) $ (0.47)
Diluted (in USD per share) [1] $ (0.18) $ (0.25) $ (0.50) $ (0.47)
Stock options        
Net loss per share attributable to common stockholders:        
Dilutive securities outstanding not included in the computation of diluted loss per share as their effect is antidilutive (shares) 570 1,187 583 1,164
Restricted shares        
Net loss per share attributable to common stockholders:        
Dilutive securities outstanding not included in the computation of diluted loss per share as their effect is antidilutive (shares) 336 281 352 264
[1] The impact of potentially dilutive securities for all periods was not considered because the effect would be anti-dilutive.